Quantification of the efficiency of cargo delivery by peptidic and pseudo-peptidic Trojan carriers using MALDI-TOF mass spectrometry

Biochimica et Biophysica Acta - Biomembranes

Volumn 1758, Issue 3, 2006, Pages 375-383

  Aussedat, Baptiste ^a   Sagan, Sandrine ^a   Chassaing, Gérard ^a   Bolbach, Gérard ^a   Burlina, Fabienne ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

Cargo delivery; Cell penetrating peptide; MALDI TOF MS; Quantification

Indexed keywords

CARRIER PROTEIN; PEPTIDE; POLYMER; PROTEIN KINASE C; PSEUDOPEPTIDE; DRUG CARRIER; OLIGOPEPTIDE; P1 PSEUDO PEPTIDIC CARRIER; P1 PSEUDO-PEPTIDIC CARRIER; P2 PSEUDO PEPTIDIC CARRIER; P2 PSEUDO-PEPTIDIC CARRIER; PENETRATIN;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; ISOTOPE LABELING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEPARATION TECHNIQUE; AMINO ACID SEQUENCE; ANIMAL; CELL CULTURE; COMPARATIVE STUDY; EVALUATION; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; DRUG CARRIERS; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33747072388     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamem.2006.01.012     Document Type: Article

References (43)

1. Derossi D., Joliot A.H., Chassaing G., and Prochiantz A. The third helix of the Antennapedia homeodomain translocates through biological membranes. J. Biol. Chem. 269 (1994) 10444-10450
2. Vives E., Brodin P., and Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272 (1997) 16010-16017
3. Ragin A.D., Morgan R.A., and Chmielewski J. Cellular import mediated by nuclear localization signal peptide sequences. Chem. Biol. 9 (2002) 943-948
4. Ragin A.D., and Chmielewski J. Probing essential residues for cellular uptake with a cationic nuclear localization signal sequence. J. Pept. Res. 63 (2004) 155-160
5. Pooga M., Hallbrink M., Zorko M., and Langel U. Cell penetration by transportan. FASEB J. 12 (1998) 67-77
6. Scheller A., Wiesner B., Melzig M., Bienert M., and Oehlke J. Evidence for an amphipathicity independent cellular uptake of amphipathic cell-penetrating peptides. Eur. J. Biochem. 267 (2000) 6043-6050
7. Futaki S., Suzuki T., Ohashi W., Yagami T., Tanaka S., Ueda K., and Sugiura Y. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J. Biol. Chem. 276 (2001) 5836-5840
8. Rothbard J.B., Kreider E., VanDeusen C.L., Wright L., Wylie B.L., and Wender P.A. Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. J. Med. Chem. 45 (2002) 3612-3618
9. Fernandez-Carneado J., Kogan M.J., Castel S., and Giralt E. Potential peptide carriers: amphipathic proline-rich peptides derived from the N-terminal domain of gamma-zein. Angew. Chem., Int. Ed. 43 (2004) 1811-1814
10. Umezawa N., Gelman M.A., Haigis M.C., Raines R.T., and Gellman S.H. Translocation of a beta-peptide across cell membranes. J. Am. Chem. Soc. 124 (2002) 368-369
11. Dietz G.P., and Bahr M. Delivery of bioactive molecules into the cell: the Trojan horse approach. Mol. Cell. Neurosci. 27 (2004) 85-131
12. Derossi D., Chassaing G., and Prochiantz A. Trojan peptides: the penetratin system for intracellular delivery. Trends Cell. Biol. 8 (1998) 84-87
13. Lindgren M., Hällbrink M., and Langel U. In: Langel U. (Ed). Cell-Penetrating Peptides Processes and Applications (2002), CRC PRESS, Boca Raton, FL 263-275
14. Zhang X., Wan L., Pooyan S., Su Y., Gardner C.R., Leibowitz M.J., Stein S., and Sinko P.J. Quantitative assessment of the cell penetrating properties of RI-Tat-9: evidence for a cell type-specific barrier at the plasma membrane of epithelial cells. Mol. Pharm. 1 (2004) 145-155
15. Gammon S.T., Villalobos V.M., Prior J.L., Sharma V., and Piwnica-Worms D. Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptake. Bioconjug. Chem. 14 (2003) 368-376
16. Richard J.P., Melikov K., Vives E., Ramos C., Verbeure B., Gait M.J., Chernomordik L.V., and Lebleu B. Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278 (2003) 585-590
17. Fischer R., Waizenegger T., Kohler K., and Brock R. A quantitative validation of fluorophore-labelled cell-permeable peptide conjugates: fluorophore and cargo dependence of import. Biochim. Biophys. Acta 1564 (2002) 365-374
18. Hallbrink M., Floren A., Elmquist A., Pooga M., Bartfai T., and Langel U. Cargo delivery kinetics of cell-penetrating peptides. Biochim. Biophys. Acta 1515 (2001) 101-109
19. Lindgren M.E., Hallbrink M.M., Elmquist A.M., and Langel U. Passage of cell-penetrating peptides across a human epithelial cell layer in vitro. Biochem. J. 377 (2004) 69-76
20. Lindgren M., Gallet X., Soomets U., Hallbrink M., Brakenhielm E., Pooga M., Brasseur R., and Langel U. Translocation properties of novel cell penetrating transportan and penetratin analogues. Bioconjug. Chem. 11 (2000) 619-626
21. Kaplan I.M., Wadia J.S., and Dowdy S.F. Cationic TAT peptide transduction domain enters cells by macropinocytosis. J. Control. Release 102 (2005) 247-253
22. Oehlke J., Scheller A., Wiesner B., Krause E., Beyermann M., Klauschenz E., Melzig M., and Bienert M. Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim. Biophys. Acta 1414 (1998) 127-139
23. Drin G., Mazel M., Clair P., Mathieu D., Kaczorek M., and Temsamani J. Physico-chemical requirements for cellular uptake of pAntp peptide. Role of lipid-binding affinity. Eur. J. Biochem. 268 (2001) 1304-1314
24. Soughayer J.S., Wang Y., Li H., Cheung S.H., Rossi F.M., Stanbridge E.J., Sims C.E., and Allbritton N.L. Characterization of TAT-mediated transport of detachable kinase substrates. Biochemistry 43 (2004) 8528-8540
25. Burlina F., Sagan S., Bolbach G., and Chassaing G. Quantification of the cellular uptake of cell-penetrating peptides by MALDI-TOF mass spectrometry. Angew. Chem., Int. Ed. 44 (2005) 4244-4247
26. Girault S., Chassaing G., Blais J.C., Brunot A., and Bolbach G. Coupling of MALDI-TOF mass analysis to the separation of biotinylated peptides by magnetic streptavidin beads. Anal. Chem. 68 (1996) 2122-2126
27. Girault S., Sagan S., Bolbach G., Lavielle S., and Chassaing G. The use of photolabelled peptides to localize the substance-P-binding site in the human neurokinin-1 tachykinin receptor. Eur. J. Biochem. 240 (1996) 215-222
28. Ong S.E., and Mann M. Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 1 (2005) 252-262
29. House C., and Kemp B.E. Protein kinase C contains a pseudosubstrate prototope in its regulatory domain. Science 238 (1987) 1726-1728
30. Cacace A.M., Guadagno S.N., Krauss R.S., Fabbro D., and Weinstein I.B. The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 8 (1993) 2095-2104
31. Ways D.K., Kukoly C.A., deVente J., Hooker J.L., Bryant W.O., Posekany K.J., Fletcher D.J., Cook P.P., and Parker P.J. MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. J. Clin. Invest. 95 (1995) 1906-1915
32. Sachs C.W., Safa A.R., Harrison S.D., and Fine R.L. Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C. J. Biol. Chem. 270 (1995) 26639-26648
33. Gupta K.P., Ward N.E., Gravitt K.R., Bergman P.J., and O'Brian C.A. Partial reversal of multidrug resistance in human breast cancer cells by an N-myristoylated protein kinase C-alpha pseudosubstrate peptide. J. Biol. Chem. 271 (1996) 2102-2111
34. Eichholtz T., de Bont D.B., de Widt J., Liskamp R.M., and Ploegh H.L. A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor. J. Biol. Chem. 268 (1993) 1982-1986
35. Theodore L., Derossi D., Chassaing G., Llirbat B., Kubes M., Jordan P., Chneiweiss H., Godement P., and Prochiantz A. Intraneuronal delivery of protein kinase C pseudosubstrate leads to growth cone collapse. J. Neurosci. 15 (1995) 7158-7167
36. Hvalby O., Hemmings Jr. H.C., Paulsen O., Czernik A.J., Nairn A.C., Godfraind J.M., Jensen V., Raastad M., Storm J.F., Andersen P., et al. Specificity of protein kinase inhibitor peptides and induction of long-term potentiation. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 4761-4765
37. Harishchandran A., and Nagaraj R. Interaction of a pseudosubstrate peptide of protein kinase C and its myristoylated form with lipid vesicles: only the myristoylated form translocates into the lipid bilayer. Biochim. Biophys. Acta 1713 (2005) 73-82
38. Gras-Masse H. Lipid vector for the delivery of peptides towards intracellular pharmacological targets. J. Mol. Recognit. 16 (2003) 234-239
39. Wiedlocha A., Falnes P.O., Rapak A., Klingenberg O., Munoz R., and Olsnes S. Translocation of cytosol of exogenous, CAAX-tagged acidic fibroblast growth factor. J. Biol. Chem. 270 (1995) 30680-30685
40. Balayssac S., Burlina F., Covert O., Bolbach G., Chassaing G., and Lequin O. Comparison of penetratin and other homeodomain-derived cell-penetrating peptides: interaction in a membrane-mimicking environment and cellular uptake efficiency. Biochemistry 45 (2006) 1408-1420
41. Shen W.C., Ryser H.J., and LaManna L. Disulfide spacer between methotrexate and poly(d-lysine). A probe for exploring the reductive process in endocytosis. J. Biol. Chem. 260 (1985) 10905-10908
42. Saito G., Swanson J.A., and Lee K.D. Drug delivery strategy utilizing conjugation via reversible disulfide linkages: role and site of cellular reducing activities. Adv. Drug Deliv. Rev. 55 (2003) 199-215
43. Mitchell D.J., Kim D.T., Steinman L., Fathman C.G., and Rothbard J.B. Polyarginine enters cells more efficiently than other polycationic homopolymers. J. Pept. Res. 56 (2000) 318-325